logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Knowledgeable Technology (01274.HK) spent 67,500 Hong Kong dollars on June 2nd to repurchase 15,900 shares.

date
02/06/2026
The Wise Financial and Economic APP News reported that ZhiXing Technology (01274.HK) announced on June 2, 2026 that it spent 67,500 Hong Kong dollars to repurchase 15,900 shares.
Latest
2 m ago
Puhua and Shun (01358.HK) spent HK$469,800 on June 2 to repurchase 399,000 shares.
2 m ago
Xiaocaoyuan (00999.HK) repurchased 185,600 shares on June 2nd for 1.3358 million Hong Kong dollars.
3 m ago
Analysis: The European Central Bank is expected to raise interest rates, but the weak economy has made the outlook uncertain.
3 m ago
The first dual-target CAR-T cell injection developed by the Stone Pharmaceutical Group (01093.HK) based on mRNA-LNP (SYS 6063 injection) has received clinical trial approval in China.
3 m ago
Shiyao Group (01093.HK): Phase I clinical trial data of the new B7-H3 antibody-conjugated drug SYS6043 will be presented in the form of an oral report at the 2026 ASCO Annual Meeting.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.